The global Hemostasis And Tissue Sealing Agents Market size
is expected to reach USD 10.34 billion by 2026, according to a new report by
Grand View Research, Inc. It is projected to register a CAGR of 8.7% during the
forecast period. The agents have gained popularity over time due to their
ability to prevent blood loss. Rapid growth of minimal invasive technology and
demand for faster recovery by patients is expected to promote market growth
over the forecast period.
The hemostasis and tissue
sealing agents market is expected to witness lucrative growth over the next
seven years owing to, an increase in demand supported by rising surgery
volumes. Growth in geriatric population and prevalence of chronic conditions
are the impact rendering drivers for this industry.
Further key findings from the report suggest:
- The hemostats market is expected to expand at a
CAGR of over 8.7% over the forecast period owing to the rise in global
volume of surgeries and applicability of the product across a variety of
surgeries to avoid occurrence of hypovolemic shock, thrombocytopenia,
blood transfusions, and post-operative complications
- Flowable hemostats are a combination of active
and mechanical agents. They function by blocking blood flow and also
converting fibrinogen into fibrin for coagulation. This segment is
expected to witness a lucrative CAGR of over 10.0% from 2018 to 2026
- Some key players operating in the hemostasis and
tissue sealing agents market include Johnson & Johnson; CryoLife Inc.;
Pfizer; C R Bard; B Braun; Covidien; and Smith & Nephew. Market
participants are involved in technological advancements to ensure
sustainability and regional presence
- For instance, in March 2015, Ethicon announced
higher efficiency of EVARREST fibrin sealant patch as compared to its
substitute, TachoSil patch (Baxter). Further study would be conducted at
the St. Vincent Heart Centre of Indiana to understand added advantages
that the product can offer.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/hemostasis-tissue-sealing-agents-market
Grand View Research has
segmented the global hemostasis and tissue sealing agents market on the basis
of product and region:
Hemostasis and Tissue Sealing Agents Product Outlook
(Revenue, USD Million, 2015 - 2026)
- Topical Hemostat
- Adhesive & tissue sealant
Hemostasis and Tissue Sealing Agents Regional Outlook
(Revenue, USD Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
No comments:
Post a Comment